R
RapidClaims
Leverage AI's potential to revolutionize your medical coding tasks
About RapidClaims
RapidClaims is a healthcare technology company founded in 2023 by Dushyant Mishra (CEO), Jot Sarup Singh (CPTO), and Abhinay Vyas (CDO), all alumni of IIT Kharagpur. The company operates on a business-to-business (B2B) SaaS model, providing an AI-powered platform to automate and streamline revenue cycle management (RCM) for healthcare providers. The impetus for the company came from CEO Dushyant Mishra's observations of hospital financial challenges during his time at Abbott Healthcare, a perspective that gained urgency with rising claim denial rates in the U.S. and advancements in Large Language Models (LLMs).
The firm targets inefficiencies in the U.S. healthcare system, where claim denials and administrative overhead result in significant annual losses for providers. RapidClaims' core business is centered on leveraging artificial intelligence to automate medical coding, a primary source of claim denials, thereby helping healthcare organizations reduce costs, accelerate reimbursements, and improve compliance. Its client base includes a range of healthcare providers, from large Federally Qualified Health Centers (FQHCs) and physician groups to outpatient clinics and ambulatory surgery centers. The company's revenue model is primarily transaction-based, charging clients for each patient chart its system reviews.
The technology platform integrates with over 15 existing electronic health record (EHR) systems, allowing for swift implementation. It offers a suite of products, including: *RapidCode*, for fully autonomous medical coding; *RapidAssist*, a tool that aids human coders by auditing charts and identifying documentation gaps; and *RapidRisk*, which focuses on risk-adjusted coding for value-based care models. The platform's AI models are designed to be customizable to a specific hospital's coding style and can process charts across more than 25 medical specialties with high accuracy. This approach aims to reduce coding-related denials and operational costs significantly.
Since its inception, RapidClaims has demonstrated notable growth and investor confidence. The company emerged from stealth in early 2024 with a $3.1 million seed funding round led by Together Fund. This was followed by an $8 million Series A round in April 2025, led by Accel, bringing its total funding to over $11 million. These funds are earmarked for accelerating go-to-market strategies, expanding its sales and marketing teams, and further enhancing its AI technology.
Source: Dealroom company dataAt a glance
- Founded
- 2023
- Headquarters
- New York City, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Open roles
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed7 investors entered at this stage
Ankit Jain
Together Fund
Better Capital
DeVC India
Oscar Benavidez
Neon
peercheque
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about RapidClaims on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RapidClaims on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
